with an
Acco share
you get a discount on Acco-titles, office supplies and selected titles.
Content
The first manual to combine practical clinical information for both hematology and oncology. This resource provides a definitive focus on the often confusing combined practice of hematology and oncology. Covers all therapy induced complications and disorders as well as chemotherapy and supportive care regimens and comprehensive coverage of all drugs used in treatment. Tito Fojo, MD Director of Clinical Research ,National Cancer Institute ,National Institutes of Health ,Bethesda, Maryland James Frame, MD Professor of Medicine ,University of West Virginia ,Director, University of West Virginia Oncology Center ,Charleston, West Virginia Peter Lebowitz, MD ,Clinical Fellow ,Medical Oncology Clinical Research Unit ,National Cancer Institute ,National Institutes of Health ,Bethesda, Maryland Michael Boydiazakis, MD ,Clinical Fellow ,Medical Oncology Clinical Research Unit National Cancer Institute ,Naitonal Institues of Health ,Bethesda, Maryland Features - First book to bridge the disciplines of hematolgy and oncology in a practical and clinical way. BENEFIT: Synthesizes these two areas into a cohesive whole. Nearly all training fellows are now double boarding in hematology and oncology. -Imbued with National Cancer Institute strategies and philosophy for disease management. BENEFIT: Reflects the authority of one of the world"s leading centers for education, research, and treatment. - Includes all practice guideline recommendations from the National Cancer Institute, American Society of Clinical Oncology, and American Society of Hematology. BENEFIT: An important summation of state-of-the-art practice guidleines from the leading organizations. - Very clinically oriented and prescriptive. BENEFIT: All about precise drug dosages and potential combinations for tailoring multi-drug regimens -- immediately applicable to daily practice. Contents SECTION A -Adrenal cancer -AIDS 'related malignancies -Anal cancer -Biliary tract cancer -Bladder cancer -Breast cancer -Carcinoid tumors -Carcinoma of Unknown Primary -Central nervous system tumors -Cervical cancer -Colorectal cancer -Esophageal cancer -Endometrial cancer -Gastric cancer -Head and Neck cancer -Hepatocellular cancer -Leukemia- Acute lymphocytic leukemia -Leukemia- Acute myelogenous leukemia -Leukemia- Chronic lymphocytic leukemia -Leukemia- Chronic myelogenous leukemia -Leukemia-Hairy cell -Lung cancer -Lymphoma- Hodgkin's Lymphomas -Lymphoma-Non-Hodgkin's Lymphomas -Melanoma -Mesothelioma -Multiple Myeloma -Ovarian cancer -Pancreatic cancer -Prostate cancer -Renal cancer -Sarcomas -Testicular cancer -Thymoma -Thyroid cancer -Vaginal cancer SECTION B -Oncologic emergencies -Neutropenic fever and antibiotics -Current cancer screening recommendations -Genetic counseling -Complications and follow up after stem cell transplant -Clinical indications of growth factors -Clinical indications of biphosphonates -Transfusion indications and reactions -Anti-emetic therapies -Cancer Pain Management -Hospice care-end life issues -Catheter Complications-thrombosis -Catheter Complications-infection -Common Radiation Complications -Chemotherapy Dose Adjustments